PKCδ and tissue transglutaminase are novel inhibitors of autophagy in pancreatic cancer cells

Autophagy

Volumn 3, Issue 5, 2007, Pages 480-483

  Ozpolat, Bulent ^a   Akar, Ugur ^a   Mehta, Kapil ^a   Lopei Berestein, Gabriel ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Autophagy; Pancreatic cancer; PKC ; Rottlerin; TG2

Indexed keywords

BECLIN 1; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C DELTA; UNCLASSIFIED DRUG;

ACIDITY; AUTOPHAGY; CANCER CELL CULTURE; CELL DEATH; CELL HYPOXIA; CELL STRESS; ENZYME INHIBITION; HUMAN; METABOLIC STRESS; METASTASIS; PANCREAS CARCINOMA; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 34548073361     PISSN: 15548627     EISSN: 15548635     Source Type: Journal    
DOI: 10.4161/auto.4349     Document Type: Review

References (22)

1. Kondo Y, Kanzawa T, Sawaya R, Kondo S. The role of autophagy in cancer development and response to therapy. Nat Rev Cancer 2005; 5:726-34.
2. Wang CW, Klionsky DJ. The molecular mechanim of autophagy. Mol Med 2003; 8:65-76.
3. Kirisako T, Baba M, Ishihara N, Miyazawa K, Ohsumi M, Yoshimori T, Noda T, Ohsumi Y. Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J Cell Biol 1999; 147:435-46.
4. Toth S, Nagy K, Palfia Z, Rez G. Cellular autophagic capacity changes during azaserine-induced tumour progression in the rat pancreas: Up-regularion in all premalignant stages and down-regulation with loss of cycloheximide sensitivity of segregation along with malignant transformation. Cell Tissue Res 2002; 309:409-16.
5. Qu X, Yu J, Bhagat G, Furuya N, Hibshoosh H, Troxel A, Rosen J, Eskelinen EL, Mizushima N, Ohsumi Y, Cattoretti G, Levine B. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J Clin Invest 2003; 112:1809-20.
6. Futreal PA, Söderkvist P, Marks JR, Iglehart JD, Cochran C, Barrett JC, Wiseman RW. Detection of frequent allelic loss on proximal chromosome 17q in sporadic breast carcinoma using microsatellite length polymorphisms. Cancer Res 1992; 52:2624-27.
7. Saito H, Inazawa S, Kasmuni F, Koi S, Sagae S, Kudo R, Saito J, Noda K, Nakamura Y. Detailed deletion mapping of chromosome 17q in ovarian and breast cancers: 2-cM region on 17q21.3 often and commonly deleted in tumors. Cancer Res 1993; 53:3382-5.
8. Akar U, Ozpolat O, Mehta K, Fok J, Kondo Y, Lopez-Berestein G. Tissue transglutaminase inhibits autophagy in Pancreatic cancer cells. Mol Cancer Res 2007; 5:241-49.
9. Koivunen J, Aaltonen V, Peltonen J. Protein kinase C (PKC) family in cancer progression. Cancer Lett 2006; 235:1-10.
10. Jackson DN, Foster DA. The enigmatic protein kinase Cδ: Complex roles in cell proliferation and survival. FASEB J 2004; 18:627-36.
11. La Porta CA, Di Dio A, Porro D, Comolli R. Overexpression of novel protein kinase Cδ in BL6 murine melanoma cells inhibits the proliferative capacity in vitro but enhances the metastatic potential in vivo. Melanoma Res 2000; 10:93-102.
12. Satoh A, Gukovskaya AS, Nieto JM, Cheng JH, Gukosky I, Reeve JR, Shimosegawa T, Pandol SJ. PKC-δ and -ε regulate NF-κB activation induced by cholecystokinin and TNF-α in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol 2004; 287:G582-91.
13. Mann AP, Verma A, Sethi G, Manavathi B, Wang H, Fok JY, Kunnumakkara AB, Kumar R, Aggarwal BB, Mehta K. Overexpression of tissue transglutaminase leads to constitutive activation of nuclear Factor-κB in cancer cells: Delineation of a novel pathway. Cancer Res 2006; 66:8788-95.
14. Fabre C, Carvalho G, Tasdemir E, Braun T, Ades L, Grosjean J, Boehrer S, Me'rivier D, Souquere S, Pierron G, Fenaux P, Kroemer G. NF-κB inhibition sensitizes to starvation-induced cell death in high-risk myelodysplastic syndrome and acute myeloid leukemia. Oncogene 2007; In press.
15. Lorand L, Graham RM. Transglutaminases: Crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4:140-56.
16. Mhaouty-Kodja S. Ghα/tissue transglutaminase 2: An emerging G protein in signal transduction. Biol Cell 2004; 96:363-67.
17. Fesus L, Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett 2005; 579:3297-302.
18. Herman JF, Mangala LS, Mehta K. Implications of increased tissue transglutaminase (TG2) expression in drug-resistant breast cancer (MCF-7) cells. Oncogene 2006; 25:3049-58.
19. Mehta K, Fok J, Miller FR, Koul D, Sahin AA. Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer. Clin Cancer Res 2004; 10:8068-76.
20. Verma A, Wang H, Manavathi B, Fok JY, Mann AP, Kumar R, Mehta K. Increased expression of tissue transglutaminase in pancreatic ductal adenocarcinoma and its implications in drug resistance and metastasis. Cancer Res 2006; 66:10525-33.
21. Elsasser HP, MacDonald R, Dienst M, Kern HF. Characterization of a transglutaminase expressed in human pancreatic adenocarcinoma cells. Eur J Cell Biol 1993; 61:321-8.
22. Iacobuzio-Donahue CA, Ashfaq R, Maitra A, Adsay NV, Shen-Ong GL, Berg K, Hollingsworth MA, Cameron JL, Yeo CJ, Kern SE, Goggins M, Hruban RH. Highly expressed genes in pancreatic ductal adenocarcinomas: A comprehensive characterization and comparison of the transcription profiles obtained from three major technologies. Cancer Res 2003; 63:8614-22.